Daviet
Brad Daviet, Memphis, TN US
Patent application number | Description | Published |
---|---|---|
20160138522 | AUTOMATED, OSCILLATING DUAL-CHAMBERED HEAT PUMP, ELECTRICITY GENERATING, AND/OR WATER HEATING METHOD EMPLOYING SUCH - Heat pump configurations that provide continuous heat transfer capabilities without any need for electricity. The overall system includes a rotatable hourglass structure situated within a sphere or ovoid container with internal tracks aligned with wheels on the hourglass. With a heat collection component situated on the underside of the container, the rotatable hourglass, being constructed of suitable heat transfer materials, absorb the collected heat in the lower portion of the container, thereby causing the air present therein to expand, forcing a plunger upward from one hourglass chamber to the other. The plunger effectuates operation of a magnetic switch to release the hourglass to rotate and then oscillate from one position to another until the heat collection operation discontinues. With a coolant introduced within the heated chamber (and drawn through pressure differential), heat can be transferred thereto. The heated coolant is then transferred to a reservoir for future utilization. | 05-19-2016 |
Christian Daviet, Paris FR
Patent application number | Description | Published |
---|---|---|
20090090359 | Respiratory Anaesthesia Apparatus with Device for Measuring the Xenon Concentration - Apparatus for respiratory anaesthesia of a patient by administration of a gas containing gaseous xenon, with a main gas circuit which is open or closed and has an inhalation branch and an exhalation branch, means for supply of gaseous xenon to the inhalation branch of the main circuit, and means for determining the xenon concentration. The means for determining the xenon concentration comprise at least one hot-wire sensor having at least one electrically conducting wire in direct contact with the gaseous flow containing the xenon, calculating means that cooperate with the hot-wire sensor(s) in order to determine the xenon concentration (Xe %) in the flow, means for generating an electrical current in order to generate a current in at least one hot wire, and means for voltage measurement that can measure at least one voltage value at the terminal of at least one hot wire or at least one resistance arranged in series with at least one hot wire. The calculating means cooperate with the voltage measurement means in such a way as to determine the xenon concentration (Xe %). | 04-09-2009 |
20090126733 | XENON RECOVERY FROM AMBIENT PRESSURE VENTILATOR LOOP - Xe exhaled from a patient is recovered with a polymeric membrane. | 05-21-2009 |
20110105934 | IMPROVEMENT IN THE PRECISION OF XENON CONTENT MEASUREMENT IN A VENTILATORY ANESTHESIA APPARATUS - The invention relates to an apparatus for the ventilatory anaesthesia of a patient by administration of a gas containing gaseous xenon that comprises a main gas circuit (CP) and a means for determining the xenon content (S | 05-05-2011 |
Gilles R. Daviet, Greenville, SC US
Patent application number | Description | Published |
---|---|---|
20110111075 | TIRE MOLD WITH POSITIVE MOLD OPENING SYSTEM - A curing mold includes an upper mold portion having a plurality of upper and lower sections radially translatable between open and closed positions, wherein each of the lower sections are positioned adjacent one of the upper sections to form a plurality of pairs of upper and lower sections. The tire mold also includes a pin extending from a first section of each pair of sections, and an aperture extending within a second section of each pair of sections, the aperture including an opening and positioned for receiving a portion of the pin extending from the corresponding first section when the mold is in a substantially closed position. Particular embodiments of the present invention also include a first plurality of radially translatable sections arranged to form an expandable ring and one or more first synchronization members extending between adjacent sections of the first plurality of sections. | 05-12-2011 |
Lauren Daviet, Geneva 8 CH
Patent application number | Description | Published |
---|---|---|
20140113343 | MODIFIED MICROORGANISMS AND USE THEREOF FOR TERPENE PRODUCTION - The present invention relates to the control of gene expression by a heterologous glucose-regulated promoter, to microorganisms in which gene expression is controlled by a heterologous glucose-regulated promoter and to methods using said microorganisms for the production of terpenes during glucose-limited fed-batch fermentation. | 04-24-2014 |
Laurent Daviet, Vetraz Monthoux FR
Patent application number | Description | Published |
---|---|---|
20090181972 | Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications - The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use. | 07-16-2009 |
20090215786 | NOVEL CYSTEINE PROTEASE INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS - The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use. | 08-27-2009 |
20110237644 | UBIQUITIN SPECIFIC PROTEASES RESPONSIBLE FOR MCL-1 STABILITY AND USES THEREOF - Use of a polypeptide selected from the group consisting of USP13, USP26, USP38, USP42 or USP46 as a screening tool for an agent for treating cancer. | 09-29-2011 |
Laurent Daviet, Geneva CH
Patent application number | Description | Published |
---|---|---|
20150079646 | GENETICALLY ENGINEERED YEAST CELLS - The present invention relates to yeast cells producing high levels of acetoacetyl-CoA. It also relates to a method for making such yeast cells and to the use of such yeast cells in a method for producing acetyl-CoA derived products. | 03-19-2015 |
Laurent Daviet, Antony FR
Patent application number | Description | Published |
---|---|---|
20100048575 | NOVEL TETRACYCLIC INHIBITORS OF CYSTEINE PROTEASES, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS - The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use: Formula (I) wherein R3, R4, R5, R6, Y, Het1, T, U, V, W, X, Ru, Rv and Rw are as defined in claim | 02-25-2010 |